trs01
Peptideexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Feb 29, 2020 (NCT04222712)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05042609 | Phase 3 | Sep 20, 2021 | Lexitas, Tarsier Pharma |
| NCT04222712 | Phase 1/Phase 2 (Phase 2) | Feb 29, 2020 | Tarsius Pharma |
| NCT04222725 | Phase 1/Phase 2 (Phase 2) | Feb 29, 2020 | Tarsius Pharma |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tarsius Pharma | For profit | 2 | 2 | 1 | 2020 |
| Lexitas | For profit | 1 | 0 | 1 | 2021 |
| Tarsier Pharma | For profit | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1